David Pidduck

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) revenue decreased 11.24% to $4.88 million in Q1 2022 compared to $5.5 million in Q1 2021. Q1 Financial Highlights Gross profit was a loss of $403,000 compared to a loss of $680,000 in 2021 Net loss was $7.46 million, compared to a net...